Fixed-dose combinations of oral GLP-1 RAs with other glucose-lowering agents in development are still a rarity, and this is the first GLP-1 plus SGLT2 in one tablet. HDM1010 tablets are a fixed-dose combination of an SGLT2 inhibitor and HDM1002, a potent, highly selective, orally active small-molecule GLP-1 receptor agonist — essentially an SGLT2/GLP-1 combo! https://lnkd.in/eHKg-crF…